Showing results (161-170 of 734) with videos related to
Sort By:
Pageof 74
Genes, Chromosomes & Cancer|March 5, 2014
Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samplesEva Maria Murga Penas, Georgia Schilling, Petra Behrmann, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 18, 2014
Exercise training in patients with advanced gastrointestinal cancer undergoing palliative chemotherapy: a pilot studyWiebke Jensen, Freerk T Baumann, Alexander Stein, et al.British Journal of Cancer|January 17, 2024
Soluble lymphocyte activation gene-3 (sLAG3) and CD4/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignanciesJoao Gorgulho, Christoph Roderburg, Fabian Beier, et al.Frontiers in Immunology|September 14, 2023
Peripheral blood CD3+HLADR+ cells and associated gut microbiome species predict response and overall survival to immune checkpoint blockadeJoao Gorgulho, Christoph Roderburg, Fabian Beier, et al.Cancer Biomarkers : Section a of Disease Markers|September 8, 2011
MDM2 amplification is an independent prognostic feature of node-negative, estrogen receptor-positive early-stage breast cancerMatthias Choschzick, Uwe Heilenkötter, Annette Lebeau, et al.Investigational New Drugs|May 31, 2007
Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumorsSandra Mueller, Ulrike Hartmann, Frank Mayer, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 31, 2010
Physical activity, quality of life, and the interest in physical exercise programs in patients undergoing palliative chemotherapyKarin Oechsle, Wiebke Jensen, Tobias Schmidt, et al.JCO Precision Oncology|September 27, 2021
Impact of Disease Evolution on Efficacy Outcomes From Larotrectinib in Patients With Locally Advanced or Metastatic Tropomyosin Receptor Kinase Fusion-Positive Solid TumorsCarsten Bokemeyer, Gilles Vassal, Antoine Italiano, et al.Molecular Cancer|May 18, 2011
Micro-RNA expression in cisplatin resistant germ cell tumor cell linesMatthias Port, Stephanie Glaesener, Christian Ruf, et al.European Journal of Haematology|November 28, 2015
Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemiaNicole Degwert, Emily Latuske, Gabi Vohwinkel, et al.Pageof 74